Merck (MRK) Net Cash Flow (2009 - 2026)

Merck (MRK) has reported Net Cash Flow for 18 consecutive years, with $1.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 248.11% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was -$1.2 billion, a 69.15% increase from a year earlier, with the FY2025 full-year figure at $809.0 million, down 87.93% from the prior year.
• Net Cash Flow was $1.5 billion for Q2 2026 at Merck, up from -$9.3 billion in the prior quarter.
• Over five years, Net Cash Flow peaked at $10.2 billion in Q3 2025 and troughed at -$9.3 billion in Q1 2026.
• A 5-year average of -$61.3 million and a median of -$250.5 million in 2022 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow sank 712.35% in 2023 and jumped 248.11% in 2026, its largest moves.
• Over 5 years, Net Cash Flow stood at $1.1 billion in 2022, then tumbled by 272.52% to -$1.9 billion in 2023, then surged by 48.46% to -$1.0 billion in 2024, then tumbled by 258.23% to -$3.6 billion in 2025, then soared by 142.58% to $1.5 billion in 2026.
• The last three Net Cash Flow figures came in at $1.5 billion (Q2 2026), -$9.3 billion (Q1 2026), and -$3.6 billion (Q4 2025), per Business Quant data.